OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
RVP
Retractable Technologies, Inc.
There isn't enough reported data to score RVP yet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
RVP Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
RVP's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
RVP PE Valuation
RVP has no meaningful PE right now: it lost money over the past year.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
RVP Forward outlook
There aren't enough analyst estimates for RVP to show an outlook.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over RVP on earnings quality, reporting a profit while its opponent remains loss making.
RVP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.15 |
| Q1 2026 | -$0.22 | +$0.54 |
| Q4 2025 | -$0.43 | -$0.03 |
| Q3 2025 | -$0.20 | +$0.34 |
| Q2 2025 | -$0.28 | +$0.33 |
| Q1 2025 | -$0.76 | -$0.50 |
| Q4 2024 | -$0.40 | -$0.16 |
| Q3 2024 | -$0.54 | -$0.17 |
RVP is still losing money, but far less than before: $0.13 per share over the past year, against $0.76 at its worst in early 2025.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over RVP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over RVP on profitability, with a higher operating margin.
RVP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.2M | -31% |
| Q1 2026 | $7.2M | -13% |
| Q4 2025 | $9.4M | +4% |
| Q3 2025 | $10.1M | -2.5% |
| Q2 2025 | $10.4M | +73% |
| Q1 2025 | $8.3M | +9.2% |
| Q4 2024 | $9.1M | -36% |
| Q3 2024 | $10.3M | +0.1% |
RVP's revenue has slid since its 2021 peak: $7M last quarter, down 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -71% | -22 points |
| Q1 2026 | -86% | -30 points |
| Q4 2025 | -82% | -2.1 points |
| Q3 2025 | -36% | +13 points |
| Q2 2025 | -49% | +47 points |
| Q1 2025 | -56% | -17 points |
| Q4 2024 | -80% | -60 points |
| Q3 2024 | -50% | -41 points |
RVP's operating margin was −71% last quarter, down 22 points from the same quarter a year ago.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over RVP on cash generation, producing positive trailing cash flow while its opponent burns cash.
RVP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | +$2.3M |
| Q1 2026 | -$1.4M | +$187.9K |
| Q4 2025 | -$596.5K | +$806.3K |
| Q3 2025 | -$1.3M | +$5.2M |
| Q2 2025 | -$4.1M | -$1.2M |
| Q1 2025 | -$1.6M | +$686.6K |
| Q4 2024 | -$1.4M | -181% |
| Q3 2024 | -$6.5M | -185% |
RVP has burned cash in most quarters: −$5M over the past year, against −$14M the year before.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
RVP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | -0.8% | -232K shares |
| 5 years | -13% | -4.4M shares |
| Available history | -8.4% | -2.7M shares |
RVP has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | $4.8M |
| Q3 2022 | — |
| Q2 2022 | $270,453 |
| Q1 2022 | $2.5M |
| Q4 2021 | $2.4M |
| Q3 2021 | $2.7M |
| Q2 2021 | $154,424 |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
RVP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -4.8x | Net Cash |
| Q3 2022 | -0.3x | Net Cash |
| Q2 2022 | -0.4x | Net Cash |
| Q1 2022 | -0.7x | Net Cash |
| Q4 2021 | -0.4x | Net Cash |
| Q3 2021 | -0.3x | Net Cash |
| Q2 2021 | -0.3x | Net Cash |
| Q1 2021 | -0.6x | Net Cash |
RVP has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
RVP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 1.7 | Oversold |
RVP's weekly RSI is 33 (neutral) and its Stochastic is 2 (oversold).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
RVP PE vs Healthcare Sector
| Metric | RVP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
RVP has no meaningful PE right now: it lost money over the past year.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over RVP on trend strength, trading above more of its moving averages.
RVP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.61 | 8.2% below |
| 20 week MA | $0.66 | 15% below |
| 50 week MA | $0.69 | 19% below |
| 100 week MA | $0.73 | 23% below |
| 200 week MA | $0.96 | 42% below |
RVP is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over RVP on returns for 2026, with the stronger performance.
RVP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.47 | $11.3 | +669% |
| 2021 | $11.3 | $6.98 | -38% |
| 2022 | $6.98 | $1.74 | -75% |
| 2023 | $1.74 | $1.11 | -36% |
| 2024 | $1.11 | $0.68 | -39% |
| 2025 | $0.68 | $0.83 | +22% |
| 2026 YTD | $0.83 | $0.56 | -33% |
RVP's yearly returns have swung widely, from +669% in 2020 to −75% in 2022. It's down 33% so far in 2026.